PubMed lists PMID 41719502 in Blood advances as Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. 1
This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. 1